Advice You - Business

We may not be too far form a time when there is very little point in holding

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

a conference for large numbers of delegates simply to relay informatio

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

n, because data will be disseminated in a variety of other ways on personal c

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ommunication systems. There will be no need to have a conference to exchange

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

information.

Now the third millennium is here, we might legitimately ask our

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

selves how we should best communicate with large numbers of people if data ca

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

n be sent so cheaply and easily around the world. There are still vast confer

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ence centers being built both by governments and commercial groups. What sort

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

of conferences do they think they will attract in this new age of instant, r

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

eliable communication?

The future of conferences must surely lie in how they

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

are used. Perhaps promoting attitude change, creating group loyalty and rewa

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

rding positive behavior could be the answer. In the future, attending a confe

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

rence will be an exciting occasion where the delegates expect to learn someth

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ing they did not know, be converted to a new way of thinking about the sponso

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

rs' products or ideas or be rewarded for having done a good job. Concentratin

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

g on audience attitude changes and perceptions will be what conferenc

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

e organizers of the future will be paid to do. A successful conferen

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ce will be one where the audience experiences a major shift in attitude, rath

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

er than collects vast amounts of corporate information. Listening to what the

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

delegate is thinking and measuring what they got will become the key issues.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/20463/adviceyou-Conferences-to-Change-Attitudes.html">Conferences to Change Attitudes</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/20463/adviceyou-Conferences-to-Change-Attitudes.html]Conferences to Change Attitudes[/url]

Looking at the advantages of hiring a debt collection agency no matter how big or small your business may be.

Do Brands really die or do they simply fade away? How come we have brand names, which are all the rage and then within a few years the fad fades away? Remember Izod or Alligator Shirts and Socks? Well where are they now? Did you know they are trying to remake themselves and in Europe on their website they now say it is a crocodile?

Have you lost potentially good employees because they have failed to understand and failed to fit into your workplace. The difference between a new employee being a success or failure is often down to how he or she is welcomed in the first few days and weeks. Here are 15 tips on how to welcome your new emplyees.

Tags

Links

Advice You - Conferences to Change Attitudes

Related Articles: